Jazz Pharmaceuticals

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell JAZZ and other ETFs, options, and stocks.

About JAZZ

Jazz Pharmaceuticals Plc operates as a biopharmaceutical company, which focuses on the identification, development, and commercialization of pharmaceutical products in the areas of narcolepsy, oncology, pain, and psychiatry. Its product portfolio includes: Xyrem, Xywav, Epidolex, Zepzelca, Rylaze, Vyxeos, and Defitelio.

CEO

Bruce C. Cozadd

CEOBruce C. Cozadd

Employees

2,800

Employees2,800

Headquarters

Dublin, Dublin

HeadquartersDublin, Dublin

Founded

2005

Founded2005

Employees

2,800

Employees2,800

JAZZ Key Statistics

Market cap

6.33B

Market cap6.33B

Price-Earnings ratio

12.05

Price-Earnings ratio12.05

Dividend yield

—

Dividend yield—

Average volume

1.32M

Average volume1.32M

High today

—

High today—

Low today

—

Low today—

Open price

$105.00

Open price$105.00

Volume

0.00

Volume0.00

52 Week high

$148.06

52 Week high$148.06

52 Week low

$95.49

52 Week low$95.49

JAZZ News

TipRanks 3d

Jazz Pharmaceuticals Completes Acquisition of Chimerix

Jazz Pharmaceuticals ( (JAZZ) ) has provided an announcement. On April 21, 2025, Jazz Pharmaceuticals announced the completion of its acquisition of Chimerix,...

Analyst ratings

90%

of 20 ratings

Buy

90%

Hold

10%

Sell